Exchange: NASDAQ·Updated 07:47 PM EDT
CTSO logo

CTSO Cytosorbents Corp

$0.3501
$0.0001
(0.03%)
Today
Closed $0.3501
$0.0001
(0.03%)
After Hours
Reported EarningsAug 6
Mkt Cap$21.99M
Vol462,306.00

About CTSO

CytoSorbents Corp. engages in critical care immunotherapy, investigation, and commercialization of blood purification technology. Its product portfolio includes CytoSorb, ContrastSorb XL, HemoDefend, VetResQ, and DrugSorb. The company was founded by Joseph Rubin in August 1997 and is headquartered in Princeton, NJ.
81

Extremely Bullish Sentiment

How do you feel about CTSO?

Advertisement|Remove ads.